Stephanie Schwartz

7.8k total citations · 3 hit papers
29 papers, 4.0k citations indexed

About

Stephanie Schwartz is a scholar working on Neurology, Molecular Biology and Physiology. According to data from OpenAlex, Stephanie Schwartz has authored 29 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Neurology, 10 papers in Molecular Biology and 10 papers in Physiology. Recurrent topics in Stephanie Schwartz's work include Neuroinflammation and Neurodegeneration Mechanisms (14 papers), Alzheimer's disease research and treatments (10 papers) and Inflammasome and immune disorders (6 papers). Stephanie Schwartz is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (14 papers), Alzheimer's disease research and treatments (10 papers) and Inflammasome and immune disorders (6 papers). Stephanie Schwartz collaborates with scholars based in United States, Germany and Spain. Stephanie Schwartz's co-authors include Michael T. Heneka, Angelika Griep, Markus P. Kummer, Eicke Latz, Ana Vieira‐Saecker, Douglas T. Golenbock, Ellen Gelpí, Annett Halle, Andrea Stutz and Andrea Delekate and has published in prestigious journals such as Nature, Cell and Journal of Neuroscience.

In The Last Decade

Stephanie Schwartz

29 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice

2012 2.2k citations Michael T. Heneka, Markus P. Kummer et al. Nature profile →
Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer’s disease

2017 708 citations Carmen Venegas, Sathish Kumar et al. Nature profile →
Microglia jointly degrade fibrillar alpha-synuclein cargo by distribution through tunneling nanotubes

2021 232 citations Hannah Scheiblich, Cira Dansokho et al. Cell profile →

Peers

Countries citing papers authored by Stephanie Schwartz

Since Specialization

Citations

This map shows the geographic impact of Stephanie Schwartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephanie Schwartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephanie Schwartz more than expected).

Fields of papers citing papers by Stephanie Schwartz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephanie Schwartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephanie Schwartz. The network helps show where Stephanie Schwartz may publish in the future.

Co-authorship network of co-authors of Stephanie Schwartz

This figure shows the co-authorship network connecting the top 25 collaborators of Stephanie Schwartz. A scholar is included among the top collaborators of Stephanie Schwartz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephanie Schwartz. Stephanie Schwartz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	NLRP3 regulates immunometabolism, impacting microglial function in Alzheimer’s disease 2024 ·Alzheimer s & Dementia ·Róisín M. McManus, (unknown), Angelika Griep, Francesco Santarelli, Stephanie Schwartz, Juan Ramón Perea, (unknown), Johannes C. M. Schlachetzki, David Bouvier, Mario Lauterbach, Susanne V. Schmidt, (unknown), Jesper Tegnér, Christopher K. Glass, Karsten Hiller, Eicke Latz, Michael T. Heneka	1
2	NLRP3‐directed antisense oligonucleotides reduce microglial immunoactivities in vitro 2023 ·Journal of Neurochemistry ·(unknown), (unknown), (unknown), (unknown), Angelika Griep, Stephanie Schwartz, Róisín M. McManus, Michael T. Heneka	10
3	Characterizing microglial senescence: Tau as a key player 2023 ·Journal of Neurochemistry ·(unknown), Hannah Scheiblich, Angelika Griep, Francesco Santarelli, Stephanie Schwartz, Michael T. Heneka, Christina Ising	20
4	Microglial PD‐1 stimulation by astrocytic PD‐L1 suppresses neuroinflammation and Alzheimer’s disease pathology 2021 ·The EMBO Journal ·Markus P. Kummer, Christina Ising, Christiane Kummer, Heela Sarlus, Angelika Griep, Ana Vieira‐Saecker, Stephanie Schwartz, Annett Halle, Matthias Brückner, Kristian Händler, Joachim L. Schultze, Marc Beyer, Eicke Latz, Michael T. Heneka	68
5	SFRP1 modulates astrocyte‐to‐microglia crosstalk in acute and chronic neuroinflammation 2021 ·EMBO Reports ·Javier Rueda‐Carrasco, María Jesús Martín‐Bermejo, (unknown), (unknown), Aldo Borroto, Frederic Brosseron, Markus P. Kummer, Stephanie Schwartz, José P. López‐Atalaya, Balbino Alarcón, Pilar Esteve, Michael T. Heneka, Paola Bovolenta	51
6	Microglia jointly degrade fibrillar alpha-synuclein cargo by distribution through tunneling nanotubes breakdown → 2021 ·Cell ·Hannah Scheiblich, Cira Dansokho, (unknown), Susanne V. Schmidt, Luc Bousset, Lena Wischhof, (unknown), Alexandru Odainic, Jasper Spitzer, Angelika Griep, Stephanie Schwartz, Daniele Bano, Eicke Latz, Ronald Melki, Michael T. Heneka	232
7	Quantitative proteomics of synaptosome S‐nitrosylation in Alzheimer’s disease 2019 ·Journal of Neurochemistry ·(unknown), Marc Sylvester, Nahal Brocke‐Ahmadinejad, Stephanie Schwartz, Francesco Santarelli, Volkmar Gieselmann, Thomas Klockgether, Frederic Brosseron, Michael T. Heneka	30
8	Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer’s disease breakdown → 2017 ·Nature ·Carmen Venegas, Sathish Kumar, Bernardo S. Franklin, (unknown), Rebecca Brinkschulte, Darío Tejera, Ana Vieira‐Saecker, Stephanie Schwartz, Francesco Santarelli, Markus P. Kummer, Angelika Griep, Ellen Gelpí, (unknown), Dietmar Riedel, Douglas T. Golenbock, Matthias Geyer, Jochen Walter, Eicke Latz, Michael T. Heneka	708
9	Variability and temporal dynamics of novel object recognition in aging male C57BL/6 mice 2017 ·Behavioural Processes ·Andreas Traschütz, Markus P. Kummer, Stephanie Schwartz, Michael T. Heneka	21
10	Ear2 Deletion Causes Early Memory and Learning Deficits in APP/PS1 Mice 2014 ·Journal of Neuroscience ·Markus P. Kummer, Thomas Hammerschmidt, Alfredo Martı́nez, Dick Terwel, Gregor Eichele, Anika Witten, (unknown), Monika Stoll, Stephanie Schwartz, Hans‐Christian Pape, Joachim L. Schultze, David Weinshenker, Michael T. Heneka	50
11	Pan-PPAR Modulation Effectively Protects APP/PS1 Mice from Amyloid Deposition and Cognitive Deficits 2014 ·Molecular Neurobiology ·Markus P. Kummer, (unknown), (unknown), (unknown), Robert Walczak, Dean W. Hum, Stephanie Schwartz, (unknown), Michael T. Heneka	41
12	NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice breakdown → 2012 ·Nature ·Michael T. Heneka, Markus P. Kummer, Andrea Stutz, Andrea Delekate, Stephanie Schwartz, Ana Vieira‐Saecker, Angelika Griep, (unknown), (unknown), Te‐Chen Tzeng, Ellen Gelpí, Annett Halle, Martin Körte, Eicke Latz, Douglas T. Golenbock	2167
13	Macrophage Migration Inhibitory Factor in Normal Human Skeletal Muscle and Inflammatory Myopathies 2010 ·Journal of Neuropathology & Experimental Neurology ·Jens Reimann, Susanne Schnell, Stephanie Schwartz, Karin Kappes‐Horn, Richard Dodel, Michael Bacher	25
14	Genotyping of Mycoplasma pneumoniae isolates using real-time PCR and high-resolution melt analysis 2009 ·Clinical Microbiology and Infection ·Stephanie Schwartz, Kathleen A. Thurman, Stephanie L. Mitchell, Bernard J. Wolff, Jonas M. Winchell	30
15	Identification of P1 Variants of Mycoplasma pneumoniae by Use of High-Resolution Melt Analysis 2009 ·Journal of Clinical Microbiology ·Stephanie Schwartz, (unknown), Kathleen A. Thurman, Bernard J. Wolff, Jonas M. Winchell	19
16	Interleukin-17 is a potent immuno-modulator and regulator of normal human intestinal epithelial cell growth 2005 ·Biochemical and Biophysical Research Communications ·Stephanie Schwartz, Jean‐François Beaulieu, Frank M. Ruemmele	38
17	Analysis of Eight Commercial Enzyme Immunoassay Tests for Detection of Antibodies to Mycoplasma pneumoniae in Human Serum 2004 ·Clinical and Vaccine Immunology ·Deborah F. Talkington, Susan Shott, Michael T. Fallon, Stephanie Schwartz, W. Lanier Thacker	56
18	HPV 16 E6 Blocks TNF-Mediated Apoptosis in Mouse Fibroblast LM Cells 1999 ·Virology ·Penelope J. Duerksen-Hughes, Jun Yang, Stephanie Schwartz	31
19	Virus–receptor interactions of human parainfluenza viruses types 1, 2 and 3 1999 ·Microbial Pathogenesis ·(unknown), Stephanie Schwartz, (unknown), E M Carlin, Anne Moscona	25
20	Tension Pneumothorax during Dental Anesthesia 1988 ·Anesthesia & Analgesia ·Samuel Jacob, Stephanie Schwartz	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact